• You are here :
  • Home › Poll Results

Monthly Poll Results

  • This Month's Poll
    July 2015

    Is the 'Old Boy' network still prominent in most Board appointments?

    Current Result

    Yes - 84% No - 16%

  • Previous Poll Results
    May 2015

    Are we building a biotech bubble?

    Current Result

    Yes - 40% No - 60%

  • April 2015

    Our evidence shows the difference in remuneration from the average executive employee to the top performer in similar roles is growing. Is your organisation in control of what they need to get the right executive talent?

    Yes - 100% No - 0%

  • March 2015

    Are high growth biotechs more successful if they hire their C suite from founders and other biotechs or import talent form large pharma?

    Yes - 50% No - 50%

  • February 2015

    Does the industry's traditional view of job tenure need to be re-evaluated in the current wired world of fast-moving development?

    Yes - 100% no - 0%

  • January 2015

    Will your business seek to maximise the potential in your product pipeline by engaging Interim Managers and/or expert Consultants in 2015?

    Yes - 46% No - 54%

  • December 2014

    Is it time for new evaluation systems both regulatory and access that recognise the unique nature of orphan drug development?

    Yes - 100% No - 0%

  • November 2014

    Should leadership assessment pay more attention to capability rather than competence?

    Yes - 64% No - 36%

  • October 2014

    Are the vast changes to the fabric of the life sciences dulling your firm's focus on product innovation and development?

    Yes - 50% No - 50%

  • September 2014

    Does your Talent strategy get the right input from your C-Level Executives.

    Yes - 17% No - 83%

  • July 2014

    Do you have a clear Big Data strategy?

    Yes - 42% No - 58%

  • June 2014

    The changing nature of drug/device development consistently requires new skills. Is your organisation assessing adaptability and potential with as much rigour as competence and capability?

    Yes - 43% No - 57%

  • May 2014

    Do Mega-Mergers improve a patient's access to the right treatment?

    Yes - 25% No - 75%

  • April 2014

    Does your organisation connect employee engagement to company performance?

    Yes - 50% No - 50%

  • March 2014

    Has digital biology changed the way you approach R&D?

    Yes - 82% No - 18%

  • February 2014

    Does the future of cancer treatment lie in molecular profiling?

    Yes - 75% No - 25%

  • January 2014

    Will R&D investment increase in 2014?

    Yes - 60% No - 40%

  • December 2013

    Will the financially challenging per patient funding of Orphan Drug Therapies by governments be viable long term?

    Yes - 78% No - 22%

  • December 2013

    Will the financially challenging per patient funding of Orphan Drug Therapies by governments be viable long term?

  • November 2013

    Will gene, cell and tissue regenerative treatments ever develop their potential in the West without adequate patent protection?

    Yes - 36% No - 64%

  • October 2013

    Are smaller or larger firms demonstrating more innovation in drug development?

    Smaller firms - 56% Larger firms - 44%

  • September 2013

    Does geography still have an impact on the skills base of talent within the pharmaceutical industry?

    Yes - 67% No - 33%

  • August 2013

    Due to the growing number of mergers and acquisitions, is there still a place for more therapeutically or geographically specialised CROs?

    Yes - 91% No - 9%

  • July 2013

    Do women bring a different perspective to ethical issues in the pharmaceutical industry?

    Yes - 67% No - 33%

  • June 2013

    Is big Pharma investing sufficiently in advanced therapies?

    Yes - 37% No - 63%

  • May 2013

    Most CEOs will agree on the link between the success of their organisation and their people. Does the quality of the Talent acquisition process directly contribute to organisational success?

    Yes - 83% No - 17%

  • April 2013

    Is current patent legislation really benefiting the patient?

    Yes - 25% No - 75%

  • March 2013

    Do the benefits of mitochondrial transplants in human embryos outweigh ethical dilemmas?

    Yes - 67% No - 33%

  • February 2013

    Do smaller teams get products to market faster?

    Yes - 100% No - 0%

  • January 2013

    Should Interim Management be a key element of an organisation's talent agenda?

    Yes - 69% No - 31%